The Gateway to Your Orthopaedic Recovery.

Author listing

Meet our authors and contributors and explore their latest articles, insights, and expertise
Editor-in-Chief

Editor-in-Chief 's Latest Stories

Conditions : Degenerative Sacroiliitis; Sacroiliac Joint Disruption Interventions : Device: iFuse Implant System; Other: Non-surgical management Sponsor : SI-BONE, Inc. Recruiting - verified February...
Conditions : Degenerative Sacroiliitis; Sacroiliac Joint Disruption Interventions : Device: iFuse Implant System; Other: Non-surgical management Sponsor : SI-BONE, Inc. Recruiting - verified November...
Conditions : Degenerative Sacroiliitis; Sacroiliac Joint Disruption Interventions : Device: iFuse Implant System; Other: Non-surgical management Sponsors : SI-BONE, Inc.; SI-BONE, Inc. Recruiting - ve...
To investigate how the fatigue vary over time in persons with rheumatoid arthritis (RA) and which factors that may influence the fatigue.
Condition : Osteoarthritis, Knee Interventions : Device: low intensity laser therapy (904nm); Other: Stretching exercises; Device: placebo laser therapy Sponsors : University of Sao Paulo General Hosp...
Conditions : Plaque Psoriasis; Psoriatic Arthritis; Pustular Psoriasis (Excluding a Localized); Psoriatic Erythroderma Intervention : Drug: TA-650 Sponsors : Mitsubishi Tanabe Pharma Corporation; Mits...
All participants in the MHRA's Full Feature GPRD (FF-GPRD) who have at least one electronic outpatient prescription record for etoricoxib issued by a General Practitioner during the period (April 1, 2...
Condition : Juvenile Idiopathic Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Completed - verified February 2014
All participants in the MHRA's Full Feature GPRD (FF-GPRD) who have at least one electronic outpatient prescription record for etoricoxib issued by a General Practitioner during the period (April 1, 2...
This multi-center observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment accordi...